drugset / Trial / NCT03587389

Summary

The primary objective is to measure the effect of host human genetics on the resulting immunological responses and long-term protection following rotavirus immunization of a study population of infants in Ho Chi Minh City, Vietnam. The secondary objectives are to assess the temporal immunological responses following rotavirus vaccination, and to investigate the role of maternally derived antibodies, and other factors that could potentially affect immunological responses following rotavirus vaccination. Also to assess infecting rotavirus genotypes in the vaccine failure cases.

Timeline

Start
2019-03-19
Primary completion
2022-06-30
Completion
2022-08-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Rotarix Vaccine 1.5 ml Oral